BIOMAT Database Logo BIOMAT Database Logo

Heparin assay in plasma: a comparison of five clotting methods. 1975

A N Teien, and M Lie

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D005260 Female Females
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013917 Thrombin An enzyme formed from PROTHROMBIN that converts FIBRINOGEN to FIBRIN. Thrombase,Thrombin JMI,Thrombin-JMI,Thrombinar,Thrombostat,alpha-Thrombin,beta,gamma-Thrombin,beta-Thrombin,gamma-Thrombin,JMI, Thrombin
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

A N Teien, and M Lie
[Heparin assay in plasma. Comparison of different methods (author's transl)].
June 1979, Der Anaesthesist,
A N Teien, and M Lie
A heparin-retarded plasma clotting test.
February 1954, Angiology,
A N Teien, and M Lie
Heparin assay: a comparison between titrimetric and amidolytic methods.
March 1980, Bollettino della Societa italiana di biologia sperimentale,
A N Teien, and M Lie
Comparison of lipoprotein lipase and clotting activity in lymph and plasma after heparin.
February 1961, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
A N Teien, and M Lie
A comparison of three chemical methods of assay of heparin [proceedings].
December 1979, The Journal of pharmacy and pharmacology,
A N Teien, and M Lie
Inhibition of thrombin generation by heparin and LMW heparins: a comparison of chromogenic and clotting methods.
January 1996, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
A N Teien, and M Lie
Anticoagulant activity of heparin: assay of bovine, human and porcine preparations by amidolytic and clotting methods.
August 1977, Thrombosis research,
A N Teien, and M Lie
Comparison of two methods for heparin monitoring: a semi-automated heparin monitoring device and activated clotting time during extracorporeal circulation.
December 1989, International journal of clinical monitoring and computing,
A N Teien, and M Lie
Measurement of patients' bivalirudin plasma levels by a thrombelastograph ecarin clotting time assay: a comparison to a standard activated clotting time.
May 2006, Anesthesia and analgesia,
A N Teien, and M Lie
Monitoring therapy with LMW heparin: a comparison of three chromogenic substrate assays and the Heptest clotting assay.
January 1990, Haemostasis,
Copied contents to your clipboard!